This content is restricted.
Brief
"On March 14, 2025, the National Health Surveillance Agency (Anvisa) presented key points and impacts of RDC 954/2024 for the regulated sector. The update aimed to simplify the registration procedure for medicines and address industry demands in a timely manner." "The presentation was conducted in Brasília, with high demand for participation, and made available online for real-time updates."
Highlights content goes here...
This content is restricted.

RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested